semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Polycystic Ovary Syndrome (PCOS) PCO Androgen Excess Society hyperandrogenism (hirsutism) / hyperandrogenemia (testosterone >70ng/dl) and/or oligomenorrhea (<8 spontaneous menses per year) and/or polycystic ovarian morphology on ultrasound Normal prolactin, TSH, 17-OH progesterone No evidence of androgen producing malignancy, Cushing's syndrome or acromegaly Age 18-40  Use of oral contraceptives and/or other steroid hormones 3 months prior to the study
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 19.0-55.0,  Obesity Males and females 19-55 years old BMI(body mass index) ≥ 25 kg/m^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women) Able to give informed consent  Significant variation in weight(more 10%) in the past 3 months Allergic or hypersensitive to any of the ingredients in the test products History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery History of alcohol or substance abuse Participation in any other clinical trials within past 2 months Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study Pregnant or lactating women etc
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Chronic Kidney Disease Subject is ≥ 18 and ≤75 years of age. 2. A serum creatinine level of 1.5 to 5.0 mg per deciliter (133 to 442 μmol per liter), a creatinine clearance of 20 to 70 ml per minute per 1.73 m2, with variations of less than 30 percent in the three months before randomization. 3. Persistent proteinuria (defined by urinary protein excretion of more than 0.3 g per day for three or more months which can evacuate urinary tract infection and overt heart failure [a New York Heart Association class of III or IV]). 4. Resistant hypertension. 5. Nondiabetic renal disease. 6. Subject is willing and able to comply with the protocol 7. Subject is expected to remain available for follow-up visits at the study center 8. Subject Informed Consent  Current treatment with corticosteroids, nonsteroidal antiinflammatory drugs, or immunosuppressive drugs. 2. Connective-tissue disease. 3. Obstructive uropathy. 4. Congestive heart failure (New York Heart Association class III or IV). 5. Subject has significant renovascular abnormalities (a history of prior renal artery intervention, including balloon angioplasty or stenting; double renal artery on one side, distortion, and extension ), measured by abdominal ultrasound or renal angiograms. 6. Subject has a history of myocardial infarction, unstable angina, cerebrovascular accident or alimentary tract hemorrhage in the previous 3 months. 7. Subject with sick sinus syndrome. 8. Subject has a history of allergy to contrast media; psychiatric disorders; drug or alcohol abuse; and pregnancy. 9. Enrolled in a concurrent study that may confound the results of this study
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Any Event Leading to Hospitalisation Age over 18 years Prescription of 4 or more different oral solid drugs Capable to understand german (verbally and written) Capable to give informed consent Insured by a Swiss health insurance Manages his/her pharmacotherapy without external support Obtains his/her medication from a community pharmacy Accepts to use an electronic multidrug blister pack Place of domicile in Basel-Stadt or Basel-Land  Pregnancy > 2 drugs that cannot be packed into a multidrug blister pack (e.g. fluids) Dementia, or evaluated as cognitively impaired by the responsible nurse Transplanted patient Anticoagulation with oral vitamin K antagonists Has already used a multidrug blister pack of Pharmis or a Medifilm® single dose system is visually impaired (blind) cannot push drugs through a blister refuses to allow contact to his/her regular pharmacy and GP is referred to a nursing home or to rehabilitation or another hospital at discharge
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Muscle Stiffness [1] a limited ROM of flexion, abduction, and rotation (ROM < 20% to the sound side); and [2] pain and stiffness in the shoulder region for at least 3 months  surgery on the particular shoulder, [2] rheumatoid arthritis, [3] stroke with residual shoulder involvement, [4] fracture of the shoulder complex, [5] rotator cuff deficiency, and [6] resting pain, intolerable pain, or muscle spasm during active and/or passive motion
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Gestational Diabetes Gestational age between 20 weeks 0 days and 32 weeks 0 days of gestation Singleton pregnancies Maternal age over 18 years Patients able to read and write in English or Spanish Diagnosis of gestational diabetes mellitus using supported by the American College of Obstetrics and Gynecology (ACOG) Patients identified as not requiring medical therapy (insulin or glyburide) after the first week of initial blood glucose monitoring  Diagnosis of GDM made by any method or other than the one outlined above Women with pre-existing diabetes mellitus Patients under the age of 18 years Patients known to be carrying a fetus with a fetal anomaly that requires either prenatal or postnatal surgery, requires early delivery or is at risk for intrauterine growth restriction (IUGR) Patients carrying multiple gestations Patients with past history of gastric bypass Patients with poorly controlled asthma, defined as the need for oral/inhaled corticosteroids to control symptoms Patients with chronic hypertension requiring medical therapy Patients currently on methadone/suboxone therapy Patients currently on any steroid therapy, regardless of the dose or route of administration
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Liver Transplantation Immunosuppression Have been receiving liver transplant two years ago Be 18 years or older Treatment with immunosuppression including cyclosporine or tacrolimus Having a normal liver function in the last year Not have suffered acute rejection in the last year and have no chronic rejection Submit any significant side effects from medication immunosuppressive (hypertension, creatinine greater than 1.7 mgDl, diabetes, morbid obesity, osteoporosis, hyperlipidemia, severe hirsutism, neurotoxicity novo malignancy, etc.) Etiology of underlying disease: alcoholic cirrhosis with or without hepatocarcinoma, metabolic diseases, amyloidotic polyneuropathy family, biliary atresia, fulminant hepatitis non-A, non-B, non-C, cirrhosis cryptogenic and generally causes no viral or autoimmune Patients offering sufficient guarantees of adherence to protocol Patients who give written informed consent for participate in the study It is necessary that the patient meets all criteria  Underlying disease of the autoimmune (primary sclerosing cholangitis, autoimmune cirrhosis, primary biliary cirrhosis) or epatocarcinoma about cirrhosis of viral or autoimmune Patients with chronic rejection, or acute rejection in the last year Patients with liver retransplantation patients with history of hypersensitivity or idiosyncratic reactions to methoxsalen, psoralen the compounds or any of the excipients patients with melanoma, cutaneous basal cell carcinoma or squamous cell coexistent Patients with aphakia Patients taking Oxoralen Pregnant women or nursing mothers, or adults of childbearing age not using effective contraception Participation in another clinical trial Inability to understand informed consent
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 15.0-40.0,  Polycystic Ovarian Syndrome Pelvic Endometriosis Insulin Resistance Non-insulin Dependent Diabetes Mellitus Tubal Obstruction BMI of 25-35 Kg/Mt2 2. Atleast three of the Rotterdam for diagnosis of PCOS. 3. Subjects with well stabilized Thyroid,if they had documented evidence of previousthyroid disorder  Subjects with documented diagnosis of Metabolic Syndrome. 2. Subjects with laparocopic and histopathologic diagnosis of Endometriosis. 3Subjects with Primary hyperprolectineamia. 4.Subjects with basal FSH >/=15mIU/ml. 5.Subjects with continuously elevated 17-0h-p
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 13.0-21.0,  Obstructive Sleep Apnea Syndrome Polycystic Ovary Syndrome Sleep Apnea Female Ages 13-21 PCOS BMI >95%ile (Obese group) or <85%ile (Lean group) Controls: ages 18-21, regular menses, BMI <85%ile  Breastfeeding Pregnant Use of any steroid preparations (including hormonal contraception), medications known to alter insulin secretion and/or action within 3 month (including Metformin)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Weight Loss Men and women with a BMI of 25 to 39.9 kg/m2 Able to obtain clearance for participation from their primary care physician (PCP) Have access to a computer with internet that meets Second Life system requirements  Report participating in a research project involving weight loss or PA in the previous 6 months Report a regular exercise or PA program Not weight stable (+/-2.27 kg) for 3 months prior to intake Unwilling to be randomized to phone or 2L clinics subsequent to weight loss Report being pregnant during the previous 6 months, lactating, or planned pregnancy in the following 18 months Report serious medical risk such as type 1 diabetes, cancer, recent cardiac event (i.e. heart attack, angioplasty, etc.) Report eating disorders as determined by the Eating Attitudes Test using a score of 20 or greater Report current treatment for psychological issues, or taking psychotropic medications Report adherence to specialized diet regimes, i.e., multiple food allergies, vegetarian, macrobiotic, etc Do not have access to grocery shopping and meal preparation (i.e. Military, college cafeteria plan, etc.)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Primary Care Phase I VA patients who have had some experience with care receipt through technology (e.g., home telehealth, CVT, secure messaging with providers) A second group will be conducted with patients who have not had experience receiving care through technology There are no other specific and the investigators plan to recruit both male and female Veterans, as well as minorities. Phase II Veterans who receive care from VA and are comfortable using the Internet There are no other specific and the investigators plan to recruit both male and female Veterans, as well as minorities. Phase III Veterans who receive care from Hines VA or Jesse Brown VA in a primary care/PACT clinic No subjects will be excluded based on gender, race, or ethnicity (1) adult, age 18 or over (2) assigned primary care provider in PACT clinic  A history of dementia Blindness
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-48.0,  Polycystic Ovary Syndrome Dietary Habits Physical Activity Between 18 and 48 years BMI ≥ 18 kg/m2 If ≥ 21 years old, must have completed a pelvic exam in the past 2 years In PCOS if: Confirmed PCOS diagnosis from their primary care provider  Use of oral contraceptives, fertility medications, or any drugs known to influence reproductive function Pregnant or breastfeeding
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  HIV Infection She is at least 18 years of age She reports having engaged in vaginal or anal sexual intercourse in the past 90 days in exchange for money, alcohol or other goods She reports having engaged in unprotected vaginal or anal sexual intercourse in the past 90 days with a paying sexual partner; and She reports being interested in learning about and developing her own small business  assessed to have a severe cognitive or psychiatric impairment that would interfere with the ability to provide informed consent or complete study instruments
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Obesity Binge Eating Disorder Patients of Eating Disorders Clinic with a diagnosis of Bulimia Nervosa, Eating Disorders Not Otherwise Specified 3 and 6 with Binge Eating Disorder according to research in Diagnostic and Statistical of Mental Disorders, version IV revised, who started taking Topiramate. 2. Probands with diagnosis of obesity (BMI ≥30 kg/m2 kg/m2). 3. Capable to give written informed consent. 4. Age of 18 to 50 years at screening. 5. Maternal and paternal grandparents of Mexican descent. 6. Probands without psychopharmacological treatment (including anticonvulsants) at least 4 weeks before inclusion  Subjects with alcohol or substance abuse or dependence. 2. Any psychiatric or medical disorder that requires inpatient treatment. 3. Psychosis or suicidal thoughts. 4. Abnormal blood chemistry. 5. Diabetes uncontrolled. 6. Unstable hypertension or difficult to control (criterion 7 of section). 7. Metabolic acidosis. 8. Narrow-angle glaucoma. 9. Unstable hypothyroidism or hyperthyroidism. 10. Unable or unwilling to give a blood sample. 11. Pace-makers or metal implants that would preclude the functional Magnetic Resonance Image scan. 12. Pregnant or lactating women at screening or positive blood pregnancy test. 13. Presence of any epileptic disorder. 14. Subjects unable or unlikely to follow the protocol procedures